Pharmaceutical News and Articles

Stimulant Dispensing to Children Decreased After Start of Pandemic, During Shortage

Stimulant dispensing to children aged 5 to 17 years decreased after the start of the COVID-19 pandemic and during a shortage of immediate-release mixed amphetam

Noisy Settings OK For Blood Pressure Testing

Don t worry if someone s checking your blood pressure in a loud public place. The reading they get is apt to be just as accurate as if the test were taking plac

Weight Loss Boosts Long-Term Health of Kids With Obesity

Helping kids with obesity drop pounds can have a huge impact on their future health. When these children and teens lose weight, they are less likely to have typ

Qigong Effective In Easing Low Back Pain

People with low back pain might want to look into the ancient Chinese mind-body movement exercise known as qigong, a new study published recently suggests. Qigo

Blood Test Accurately Detects Colon Cancer

An experimental blood test can effectively and accurately detect colon cancer in middle-aged folks and seniors, a new study says. The blood test was 81 accurate

Delayed Dream Sleep Linked to Alzheimer's Risk

Delays in dreaming might be an early warning sign of Alzheimer s disease. People who take significantly longer to enter the rapid eye movement (REM) phase of sl

FDA Approves Leqembi (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

Zydus Announces USFDA Orphan Drug Designation to Usnoflast for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Ahmedabad, India, January 22, 2025 Zydus, a leading, discovery-based, global pharmaceutical company today announced that the USFDA has granted Orphan Drug Desig

Findings From Pivotal Nipocalimab Phase 3 Study in a Broad Antibody Positive Population of People Living with Generalized Myasthenia Gravis (gMG) Published in The Lancet Neurology

SPRING HOUSE, Pa., (January 23, 2025) Johnson Johnson (NYSE JNJ) today announced The Lancet Neurology has published results from the pivotal Phase 3 study of ni

Novo Nordisk Successfully Completes Phase 1b/2a Trial with Subcutaneous Amycretin in People with Overweight or Obesity

Bagsv rd, Denmark, 24 January 2025 Novo Nordisk today announced topline results from a phase 1b 2a clinical trial with amycretin, a unimolecular GLP-1 and amyli